NO20003640D0 - New dosage form - Google Patents

New dosage form

Info

Publication number
NO20003640D0
NO20003640D0 NO20003640A NO20003640A NO20003640D0 NO 20003640 D0 NO20003640 D0 NO 20003640D0 NO 20003640 A NO20003640 A NO 20003640A NO 20003640 A NO20003640 A NO 20003640A NO 20003640 D0 NO20003640 D0 NO 20003640D0
Authority
NO
Norway
Prior art keywords
dosage form
new dosage
new
dosage
Prior art date
Application number
NO20003640A
Other languages
Norwegian (no)
Other versions
NO20003640L (en
Inventor
Peter Watts
Lisbeth Illum
Original Assignee
West Pharm Serv Drug Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Pharm Serv Drug Res Ltd filed Critical West Pharm Serv Drug Res Ltd
Publication of NO20003640D0 publication Critical patent/NO20003640D0/en
Publication of NO20003640L publication Critical patent/NO20003640L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20003640A 1998-01-22 2000-07-14 New dosage form NO20003640L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9801363.4A GB9801363D0 (en) 1998-01-22 1998-01-22 Novel dosage form
PCT/GB1999/000193 WO1999037290A1 (en) 1998-01-22 1999-01-20 Novel dosage form

Publications (2)

Publication Number Publication Date
NO20003640D0 true NO20003640D0 (en) 2000-07-14
NO20003640L NO20003640L (en) 2000-09-12

Family

ID=10825713

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003640A NO20003640L (en) 1998-01-22 2000-07-14 New dosage form

Country Status (9)

Country Link
EP (1) EP1059918A1 (en)
JP (1) JP2002501016A (en)
AR (1) AR014467A1 (en)
AU (1) AU2176099A (en)
CA (1) CA2318257A1 (en)
GB (1) GB9801363D0 (en)
NO (1) NO20003640L (en)
WO (1) WO1999037290A1 (en)
ZA (1) ZA99454B (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
WO2006020009A1 (en) * 2004-07-23 2006-02-23 The Procter & Gamble Company Solid oral dosage form of a bisphosphonate containing a chelating agent
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
CN102379684B (en) 2005-04-28 2014-11-19 普罗透斯数字保健公司 Pharma-informatics system
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
CA2650920C (en) 2006-05-02 2016-10-18 Proteus Biomedical, Inc. Patient customized therapeutic regimens
MY158019A (en) 2006-10-25 2016-08-30 Proteus Digital Health Inc Controlled activation ingestible identifier
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
PT3785599T (en) 2007-02-01 2022-10-21 Otsuka Pharma Co Ltd Ingestible event marker systems
CA2676280C (en) 2007-02-14 2018-05-22 Proteus Biomedical, Inc. In-body power source having high surface area electrode
WO2008112577A1 (en) 2007-03-09 2008-09-18 Proteus Biomedical, Inc. In-body device having a multi-directional transmitter
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
DK2192946T3 (en) 2007-09-25 2022-11-21 Otsuka Pharma Co Ltd In-body device with virtual dipole signal amplification
WO2009070773A1 (en) 2007-11-27 2009-06-04 Proteus Biomedical, Inc. Transbody communication systems employing communication channels
US8258962B2 (en) 2008-03-05 2012-09-04 Proteus Biomedical, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
CA3039236C (en) 2008-07-08 2022-05-17 Proteus Digital Health, Inc. Ingestible event marker data framework
CN104382598A (en) 2008-08-13 2015-03-04 普罗透斯数字保健公司 Method of producing a recognizer
SG172846A1 (en) 2009-01-06 2011-08-29 Proteus Biomedical Inc Ingestion-related biofeedback and personalized medical therapy method and system
WO2010111403A2 (en) 2009-03-25 2010-09-30 Proteus Biomedical, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
NZ596292A (en) 2009-04-28 2014-04-30 Proteus Digital Health Inc Highly reliable ingestible event markers and methods for using the same
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
TWI517050B (en) 2009-11-04 2016-01-11 普羅托斯數位健康公司 System for supply chain management
EP2555737A4 (en) 2010-04-07 2013-09-18 Proteus Digital Health Inc INDEPENDENT MINIATURE DEVICE
TWI557672B (en) 2010-05-19 2016-11-11 波提亞斯數位康健公司 Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device
JP2014504902A (en) 2010-11-22 2014-02-27 プロテウス デジタル ヘルス， インコーポレイテッド Ingestible device with medicinal product
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
CA2842952C (en) 2011-07-21 2019-01-08 Proteus Digital Health, Inc. Mobile communication device, system, and method
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
AU2013293234B2 (en) 2012-07-23 2017-08-31 Otsuka Pharmaceutical Co., Ltd. Techniques for manufacturing ingestible event markers comprising an ingestible component
DK2910013T3 (en) 2012-10-18 2018-08-06 Proteus Digital Health Inc Apparatus, system and method for adaptive optimization for power output and transmit power in a power source for a communication device
WO2014120669A1 (en) 2013-01-29 2014-08-07 Proteus Digital Health, Inc. Highly-swellable polymeric films and compositions comprising the same
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
JP6511439B2 (en) 2013-06-04 2019-05-15 プロテウス デジタル ヘルス， インコーポレイテッド Systems, devices, and methods for data collection and outcome assessment
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
MX2019000888A (en) 2016-07-22 2019-06-03 Proteus Digital Health Inc Electromagnetic sensing and detection of ingestible event markers.
TWI735689B (en) 2016-10-26 2021-08-11 日商大塚製藥股份有限公司 Methods for manufacturing capsules with ingestible event markers
US11458104B1 (en) * 2018-06-21 2022-10-04 Mission Pharmacal Company Enteric coated tiopronin tablet
CN109453166B (en) * 2018-10-16 2021-03-12 丹诺医药(苏州）有限公司 Solid dispersion of rifamycin-quinolizinone coupled molecules and application thereof
CN110613697A (en) * 2019-10-30 2019-12-27 长春迪瑞制药有限公司 Cefalexin capsule and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786508A (en) * 1986-05-30 1988-11-22 Warner-Lambert Company Coated dosage forms
FR2618331B1 (en) * 1987-07-23 1991-10-04 Synthelabo PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF UREMIA
AU618589B2 (en) * 1988-04-05 1992-01-02 Kyowa Hakko Kogyo Co. Ltd. Oral compositions for ruminants

Also Published As

Publication number Publication date
NO20003640L (en) 2000-09-12
AU2176099A (en) 1999-08-09
GB9801363D0 (en) 1998-03-18
WO1999037290A1 (en) 1999-07-29
AR014467A1 (en) 2001-02-28
EP1059918A1 (en) 2000-12-20
CA2318257A1 (en) 1999-07-29
JP2002501016A (en) 2002-01-15
ZA99454B (en) 2000-10-23

Similar Documents

Publication Publication Date Title
ATE321483T1 (en) CAN
NO20005503D0 (en) New use
NO992692L (en) Nefadozone dosage form
NO20012915D0 (en) New pharmaceutical formulation
DE60038698D1 (en) HYDROGEL-CONTROLLED DOSAGE FORM
NO20021116D0 (en) New composition
NO20005913L (en) Medicinal Composition
NO20004773D0 (en) Prolonged-release mixtures
ATE314838T1 (en) PRESSURE-DOSE INHALERS
ID29066A (en) FENILGLISINA DOWN
ID27423A (en) KUINOLIN DOWN
DE69930866D1 (en) DOSING
ID23234A (en) BENZOSULFONA DOWN
NO991944D0 (en) New connection
ID27484A (en) ADENOSINA DOWN
NO20021115L (en) New composition
ID27547A (en) KUINOLIN DOWN
EP1124578A4 (en) NEW IMMUNADJUVANZIA
NO20003996L (en) New connection
EE200000022A (en) New dosage form
DE69921275D1 (en) inhaler
FIU990494U0 (en) New composition
NO20005483D0 (en) New composition
ID28356A (en) DOWN TIAZOLA
FR2778555B1 (en) KERATOPROTHESIS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application